Zhejiang Hisun Pharmaceutical Co Ltd
SSE:600267
Intrinsic Value
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research & development, manufacture, and sale of pharmaceutical products as well as veterinary medicines. [ Read More ]
The intrinsic value of one Zhejiang Hisun Pharmaceutical Co Ltd stock under the Base Case scenario is 14.59 CNY. Compared to the current market price of 7.64 CNY, Zhejiang Hisun Pharmaceutical Co Ltd is Undervalued by 48%.
Valuation Backtest
Zhejiang Hisun Pharmaceutical Co Ltd
Run backtest to discover the historical profit from buying and selling Zhejiang Hisun Pharmaceutical Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Zhejiang Hisun Pharmaceutical Co Ltd
| Current Assets | 6.6B |
| Cash & Short-Term Investments | 1.6B |
| Receivables | 2.9B |
| Other Current Assets | 2.1B |
| Non-Current Assets | 11.5B |
| Long-Term Investments | 1.4B |
| PP&E | 8.5B |
| Intangibles | 1.4B |
| Other Non-Current Assets | 184.2m |
| Current Liabilities | 6.6B |
| Accounts Payable | 815.1m |
| Accrued Liabilities | 305.6m |
| Short-Term Debt | 3B |
| Other Current Liabilities | 2.5B |
| Non-Current Liabilities | 3B |
| Long-Term Debt | 2.5B |
| Other Non-Current Liabilities | 481.5m |
Earnings Waterfall
Zhejiang Hisun Pharmaceutical Co Ltd
|
Revenue
|
12B
CNY
|
|
Cost of Revenue
|
-7B
CNY
|
|
Gross Profit
|
4.9B
CNY
|
|
Operating Expenses
|
-3.9B
CNY
|
|
Operating Income
|
1B
CNY
|
|
Other Expenses
|
-385.8m
CNY
|
|
Net Income
|
615.1m
CNY
|
Free Cash Flow Analysis
Zhejiang Hisun Pharmaceutical Co Ltd
Profitability Score
Profitability Due Diligence
Zhejiang Hisun Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Zhejiang Hisun Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Zhejiang Hisun Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Zhejiang Hisun Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Zhejiang Hisun Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Zhejiang Hisun Pharmaceutical Co Ltd is 7.55 CNY with a low forecast of 7.47 CNY and a high forecast of 7.77 CNY.
Shareholder Return
Price
Zhejiang Hisun Pharmaceutical Co Ltd
| Average Annual Return | 4.62% |
| Standard Deviation of Annual Returns | 41.19% |
| Max Drawdown | -67% |
| Market Capitalization | 8.8B CNY |
| Shares Outstanding | 1 207 873 677 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research & development, manufacture, and sale of pharmaceutical products as well as veterinary medicines. The company is headquartered in Taizhou, Zhejiang and currently employs 8,280 full-time employees. The company went IPO on 2000-07-25. The firm's bulk pharmaceutical chemicals mainly include antineoplastic drugs, cardiovascular drugs, anti-infection drugs, endocrine control drugs, anthelmintic, as well as animal remedies, among others. The firm is also engaged in the sales of drugs manufactured by other companies. The firm distributes its products in domestic markets and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Zhejiang Hisun Pharmaceutical Co Ltd stock under the Base Case scenario is 14.59 CNY.
Compared to the current market price of 7.64 CNY, Zhejiang Hisun Pharmaceutical Co Ltd is Undervalued by 48%.
You don't have any saved screeners yet
